SAFC Introduces the First Commercially Available Novel CHOZN GS Knockout CHO Cell Line

Sigma-Aldrich Corporation

today announced that its custom manufacturing and services business unit, SAFC, is introducing a novel CHOZN® GS-/- Zinc Finger Nuclease (ZFN)-modified Chinese Hamster Ovary (

) cell line. Designed for use in the production of biopharmaceuticals, the new CHOZN GS-/- cell line is the first commercially available glutamine synthetase knockout CHO cell line proven to shorten bioproduction times in early development, enabling customers to enhance their speed-to-market and increase cost efficiency.